Jeanny Aragon-Ching, MD, FACP, of the Inova Schar Cancer Institute, Fairfax, VA, discusses current approaches to treating urothelial cancer and their limitations. She specifically mentions cisplatin-based therapy and the differenced that arise when treating ovarian cancer. This interview was recorded at the American Society of Oncology (ASCO) 2019 Annual Meeting, held in Chicago, IL.